Skye Bioscience, Inc. Proceeds from Issuance or Sale of Equity
Skye Bioscience, Inc. (SKYE) reported Proceeds from Issuance or Sale of Equity of $7.17 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2018-11-14
- Skye Bioscience, Inc. proceeds from issuance or sale of equity for the quarter ending 2018-09-30 was $0.00.
| Period end | Proceeds from Issuance or Sale of Equity 1 month | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $7.17M 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | $7.17M 10-Q · filed 2018-08-10 | |||
| 2018-02-28 | $3.96M 10-Q · filed 2018-11-14 | |||
| 2018-01-31 | $3.22M 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |